Microglial lipid metabolism and epigenetic regulation: Emerging targets for spinal cord injury therapy

Spinal cord injuries (SCI) most often result from traumatic events such as road traffic accidents, falls, or acts of violence [1]. These injuries have severe consequences and frequently leave affected individuals with permanent disabilities, leading to loss of motor, sensory, and autonomic functions. Depending on the level and severity of the lesion, patients may experience paraplegia or tetraplegia, which can be either complete or incomplete [2].